Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Boston Properties	VICI Properties	Healthpeak Properties	Duke Realty	UDR
Symbol	NYSE:BXP	NYSE:VICI	NYSE:PEAK	NYSE:DRE	NYSE:UDR
Price Information
Current Price	$116.96	$30.07	$34.64	$53.22	$53.94
50-Day Moving Average	$113.31	$29.95	$34.96	$50.71	$53.55
52-Week Low	$69.69	$22.13	$26.32	$36.80	$29.34
52-Week High	$124.24	$33.35	$37.69	$53.72	$56.31
MarketRank™
Overall Score	2.4	2.7	2.3	2.5	2.5
Analysis Score	1.1	3.5	1.3	2.4	2.3
Community Score	4.7	4.4	4.1	3.7	4.0
Dividend Score	2.5	2.5	2.5	3.3	4.2
Ownership Score	2.5	1.7	2.5	2.5	0.8
Earnings & Valuation Score	1.3	1.3	1.3	0.6	1.3
Analyst Ratings
Consensus Recommendation	Hold	Buy	Buy	Buy	Buy
Consensus Price Target	$118.71	$34.54	$35.39	$53.36	$53.80
% Upside from Price Target	1.50% upside	14.86% upside	2.16% upside	0.27% upside	-0.26% downside
Trade Information
Market Cap	$18.27 billion	$18.10 billion	$18.67 billion	$20.14 billion	$16.01 billion
Beta	1.22	1.06	0.69	0.54	0.75
Average Volume	987,022	5,520,952	3,245,695	1,796,166	1,887,799
Sales & Book Value
Annual Revenue	$2.77 billion	$1.23 billion	$1.64 billion	$993.20 million	$1.24 billion
Price / Sales	6.60	14.77	11.35	20.27	12.90
Cashflow	$10.83 per share	$1.73 per share	$1.76 per share	$1.87 per share	$2.37 per share
Price / Cash	10.80	17.43	19.68	28.52	22.75
Book Value	$52.29 per share	$17.69 per share	$13.64 per share	$14.07 per share	$10.91 per share
Price / Book	2.24	1.70	2.54	3.78	4.94
Profitability
Net Income	$872.73 million	$891.67 million	$413.56 million	$299.92 million	$64.27 million
EPS	$6.29	$1.64	$1.64	$1.52	$2.04
Trailing P/E Ratio	60.60	13.02	37.25	40.32	1,079.02
Forward P/E Ratio	16.34	15.19	20.14	29.08	24.86
P/E Growth	2.93	2.21	4.79	4.34	5.90
Net Margins	11.30%	85.88%	25.71%	45.52%	1.31%
Return on Equity (ROE)	3.86%	13.16%	-0.07%	9.40%	1.40%
Return on Assets (ROA)	1.40%	7.37%	-0.03%	5.36%	0.44%
Dividend
Annual Payout	$3.92	$1.44	$1.20	$1.02	$1.45
Dividend Yield	3.35%	4.79%	3.46%	1.92%	2.69%
Three-Year Dividend Growth	28.52%	N/A	N/A	24.68%	16.12%
Payout Ratio	62.32%	87.80%	73.17%	67.11%	71.08%
Years of Consecutive Dividend Growth	1 Years	3 Years	N/A	7 Years	12 Years
Debt
Debt-to-Equity Ratio	1.58%	0.70%	0.68%	0.67%	1.98%
Current Ratio	4.75%	8.88%	1.01%	1.02%	4.03%
Quick Ratio	4.75%	8.88%	1.01%	1.02%	4.03%
Ownership Information
Institutional Ownership Percentage	88.78%	N/A	92.79%	96.39%	N/A
Insider Ownership Percentage	1.10%	0.22%	0.22%	0.41%	2.69%
Miscellaneous
Employees	750	120	217	2,018	2,018
Shares Outstanding	156.17 million	602.05 million	538.97 million	378.34 million	296.85 million
Next Earnings Date	10/26/2021 (Confirmed)	10/27/2021 (Confirmed)	11/2/2021 (Confirmed)	10/27/2021 (Confirmed)	10/26/2021 (Confirmed)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Source	Headline
	What 9 Analyst Ratings Have To Say About UDR - Benzinga - Benzinga benzinga.com - October 12 at 1:20 PM
	UDR (NYSE:UDR) PT Raised to $58.00 americanbankingnews.com - October 12 at 8:56 AM
	UDR (NYSE:UDR) Given New $58.00 Price Target at KeyCorp marketbeat.com - October 12 at 7:10 AM
	Luxury Orlando apartment complex sells in record-smashing deal finance.yahoo.com - October 7 at 10:12 AM
	Here's Why It is Wise to Retain UDR Stock in Your Portfolio - Nasdaq nasdaq.com - October 6 at 1:37 PM
	Here's Why It is Wise to Retain UDR Stock in Your Portfolio finance.yahoo.com - October 6 at 1:37 PM
	Udr UDR Investment Analysis - Stock Traders Daily news.stocktradersdaily.com - October 4 at 2:46 AM
	UDR - Consensus Indicates Potential 7.7% Upside - DirectorsTalk Interviews directorstalkinterviews.com - October 3 at 10:07 AM
	UDR Inc. (UDR): What Technical Indicators Show - The Fosters Leader fostersleader.com - October 1 at 9:53 AM
	UDR Announces Dates for Third Quarter 2021 Earnings Release and Conference Call - Business Wire businesswire.com - September 30 at 6:53 PM
	UDR Announces Dates for Third Quarter 2021 Earnings Release and Conference Call finance.yahoo.com - September 30 at 6:53 PM
	UDR Inc. stock remains steady Tuesday, still outperforms market - MarketWatch marketwatch.com - September 28 at 8:26 PM
	Ex UDR soldier: I would never have missed the fine 50th anniversary tribute parade in Lisburn to an almost forgotten army - Belfast News Letter newsletter.co.uk - September 28 at 10:20 AM
	Winston Lineweaver passes, aged 79 – Harnesslink - Harnesslink harnesslink.com - September 27 at 6:27 PM
	Winston Lineweaver Obituary (1942 - 2021) - Woodstock, VA - Northern Virginia Daily - Legacy.com legacy.com - September 27 at 6:27 PM
	Well-attended talk on history of the UDR launches centenary series in Ballycarry - Larne Times larnetimes.co.uk - September 27 at 6:27 PM
	Udr Inc (UDR) Chairman and CEO Thomas W Toomey Sold $1.6 million of Shares gurufocus.com - September 27 at 6:27 PM
	UDR, Inc. Issues $200,000,000 Aggregate Principal Amount of 3.000% Medium-Term Notes, Series A Due 2031 - marketscreener.com marketscreener.com - September 25 at 6:39 PM
	UDR : Prices $200 Million of 3.000% Senior Unsecured Notes Due 2031 (Form 8-K) - Marketscreener.com marketscreener.com - September 24 at 7:50 PM
	Mid-America Apartment Communities Inc. stock outperforms competitors on strong trading day - MarketWatch marketwatch.com - September 24 at 9:43 AM
	Avalonbay Communities Inc. stock outperforms market on strong trading day - MarketWatch marketwatch.com - September 24 at 9:43 AM
	Essex Property Trust Inc. stock rises Thursday, still underperforms market - MarketWatch marketwatch.com - September 24 at 9:43 AM
	Anti-gay ex-IRA man Gerry McGeough punched at Pride parade - PinkNews pinknews.co.uk - September 24 at 9:43 AM
	Learn to Evaluate Udr (UDR) using the Charts - Stock Traders Daily news.stocktradersdaily.com - September 24 at 9:43 AM
	UDR (UDR) is a Great Momentum Stock: Should You Buy? - Nasdaq nasdaq.com - September 24 at 12:17 AM
	UDR : Goldman Sachs Reinstates UDR at Buy with $60 Price Target - marketscreener.com marketscreener.com - September 23 at 1:58 PM

Date	Company	Brokerage	Action
10/12/2021	UDR	KeyCorp	Boost Price Target
10/6/2021	VICI Properties	KeyCorp	Upgrade
10/5/2021	VICI Properties	Robert W. Baird	Reiterated Rating
9/29/2021	UDR	Mizuho	Boost Price Target
9/27/2021	VICI Properties	Robert W. Baird	Reiterated Rating
9/23/2021	UDR	The Goldman Sachs Group	Initiated Coverage
9/16/2021	Duke Realty	The Goldman Sachs Group	Boost Price Target
9/13/2021	VICI Properties	Deutsche Bank Aktiengesellschaft	Boost Price Target
9/13/2021	Healthpeak Properties	Morgan Stanley	Boost Price Target
9/13/2021	UDR	BTIG Research	Upgrade
9/1/2021	Boston Properties	Barclays	Initiated Coverage
9/1/2021	Boston Properties	Piper Sandler	Boost Price Target
9/1/2021	VICI Properties	Capital One Financial	Reiterated Rating
9/1/2021	Duke Realty	Barclays	Initiated Coverage
9/1/2021	UDR	Barclays	Initiated Coverage
9/1/2021	UDR	Piper Sandler	Boost Price Target
8/30/2021	Duke Realty	Wells Fargo & Company	Boost Price Target
8/26/2021	UDR	Wells Fargo & Company	Boost Price Target
8/23/2021	Duke Realty	Truist Securities	Boost Price Target
8/23/2021	Duke Realty	Truist	Boost Price Target
8/18/2021	UDR	Truist Securities	Boost Price Target
8/18/2021	UDR	Truist	Boost Price Target
8/17/2021	Healthpeak Properties	Royal Bank of Canada	Boost Price Target
8/5/2021	Boston Properties	Robert W. Baird	Reiterated Rating
8/5/2021	UDR	Morgan Stanley	Boost Price Target
8/3/2021	Duke Realty	Royal Bank of Canada	Boost Price Target
8/2/2021	Boston Properties	Argus	Boost Price Target
8/2/2021	Duke Realty	Robert W. Baird	Boost Price Target
7/30/2021	Duke Realty	Raymond James	Boost Price Target
7/26/2021	Healthpeak Properties	Morgan Stanley	Boost Price Target
7/23/2021	VICI Properties	Wells Fargo & Company	Boost Price Target
7/23/2021	Healthpeak Properties	Wells Fargo & Company	Boost Price Target
7/15/2021	Duke Realty	Morgan Stanley	Boost Price Target
7/15/2021	UDR	Morgan Stanley	Boost Price Target
7/15/2021	UDR	KeyCorp	Boost Price Target
7/14/2021	Boston Properties	Mizuho	Initiated Coverage
7/14/2021	Boston Properties	Morgan Stanley	Boost Price Target
7/14/2021	Healthpeak Properties	Mizuho	Reiterated Rating
7/14/2021	Duke Realty	Mizuho	Reiterated Rating
7/12/2021	Duke Realty	Raymond James	Boost Price Target
6/25/2021	Boston Properties	Deutsche Bank Aktiengesellschaft	Boost Price Target
6/17/2021	Boston Properties	Truist Securities	Boost Price Target
6/15/2021	Healthpeak Properties	Argus	Boost Price Target
6/14/2021	Boston Properties	Wolfe Research	Initiated Coverage
6/14/2021	Boston Properties	Piper Sandler	Upgrade
6/14/2021	VICI Properties	Wolfe Research	Initiated Coverage
6/14/2021	UDR	Wolfe Research	Initiated Coverage
6/11/2021	UDR	Morgan Stanley	Boost Price Target
6/7/2021	Duke Realty	Wells Fargo & Company	Boost Price Target
6/4/2021	VICI Properties	Raymond James	Boost Price Target
6/1/2021	Duke Realty	Royal Bank of Canada	Boost Price Target
5/26/2021	Healthpeak Properties	JPMorgan Chase & Co.	Reiterated Rating
5/26/2021	UDR	Morgan Stanley	Boost Price Target
5/25/2021	Boston Properties	The Goldman Sachs Group	Initiated Coverage
5/24/2021	Healthpeak Properties	Royal Bank of Canada	Boost Price Target
5/20/2021	Healthpeak Properties	Berenberg Bank	Upgrade
5/20/2021	Healthpeak Properties	JPMorgan Chase & Co.	Downgrade
5/20/2021	Duke Realty	Morgan Stanley	Boost Price Target
5/10/2021	VICI Properties	Morgan Stanley	Reiterated Rating
5/10/2021	VICI Properties	Evercore ISI	Reiterated Rating
5/6/2021	Healthpeak Properties	Barclays	Boost Price Target
5/6/2021	UDR	Morgan Stanley	Boost Price Target
5/4/2021	Boston Properties	Argus	Boost Price Target
5/3/2021	VICI Properties	Jefferies Financial Group	Boost Price Target
5/3/2021	VICI Properties	Deutsche Bank Aktiengesellschaft	Boost Price Target
5/3/2021	VICI Properties	Morgan Stanley	Downgrade
4/30/2021	Duke Realty	Raymond James	Boost Price Target
4/26/2021	VICI Properties	LADENBURG THALM/SH SH	Boost Price Target
4/21/2021	Duke Realty	Mizuho	Boost Price Target
4/19/2021	Boston Properties	Deutsche Bank Aktiengesellschaft	Boost Price Target
4/16/2021	Duke Realty	Raymond James	Initiated Coverage
4/14/2021	Boston Properties	Mizuho	Boost Price Target
4/14/2021	Healthpeak Properties	Wells Fargo & Company	Boost Price Target
3/30/2021	Healthpeak Properties	Bank of America	Upgrade
3/30/2021	UDR	Royal Bank of Canada	Initiated Coverage
3/22/2021	Boston Properties	Truist Securities	Reiterated Rating
3/15/2021	Boston Properties	Truist	Downgrade
3/15/2021	Boston Properties	Truist Securities	Downgrade
3/15/2021	VICI Properties	KeyCorp	Initiated Coverage
3/15/2021	Healthpeak Properties	Morgan Stanley	Boost Price Target
3/15/2021	UDR	Morgan Stanley	Boost Price Target
3/15/2021	UDR	Mizuho	Boost Price Target
3/7/2021	VICI Properties	Robert W. Baird	Reiterated Rating
2/25/2021	VICI Properties	Morgan Stanley	Boost Price Target
2/25/2021	UDR	Morgan Stanley	Boost Price Target
2/25/2021	UDR	KeyCorp	Boost Price Target
2/22/2021	VICI Properties	Deutsche Bank Aktiengesellschaft	Boost Price Target
2/11/2021	UDR	Piper Sandler	Upgrade
2/9/2021	Healthpeak Properties	Mizuho	Boost Price Target
2/1/2021	Duke Realty	Mizuho	Boost Price Target
1/26/2021	VICI Properties	The Goldman Sachs Group	Boost Price Target
1/20/2021	VICI Properties	Morgan Stanley	Boost Price Target
1/20/2021	Healthpeak Properties	Capital One Financial	Upgrade
1/11/2021	UDR	BMO Capital Markets	Upgrade
12/29/2020	Healthpeak Properties	Barclays	Boost Price Target
12/21/2020	Boston Properties	JPMorgan Chase & Co.	Downgrade
12/17/2020	VICI Properties	JPMorgan Chase & Co.	Initiated Coverage
12/16/2020	VICI Properties	Robert W. Baird	Initiated Coverage
12/15/2020	Boston Properties	Smith Barney Citigroup	Boost Price Target
12/15/2020	Boston Properties	Deutsche Bank Aktiengesellschaft	Downgrade
12/15/2020	VICI Properties	Smith Barney Citigroup	Boost Price Target
12/15/2020	Healthpeak Properties	Smith Barney Citigroup	Boost Price Target
12/15/2020	UDR	Smith Barney Citigroup	Boost Price Target
12/14/2020	Boston Properties	Morgan Stanley	Boost Price Target
12/14/2020	Healthpeak Properties	KeyCorp	Downgrade
12/11/2020	UDR	Wells Fargo & Company	Reiterated Rating
12/10/2020	Healthpeak Properties	Wells Fargo & Company	Downgrade
12/9/2020	VICI Properties	Deutsche Bank Aktiengesellschaft	Boost Price Target
11/16/2020	Boston Properties	Bank of America	Boost Price Target
11/16/2020	Boston Properties	Argus	Boost Price Target
11/16/2020	VICI Properties	Loop Capital	Initiated Coverage
11/11/2020	Duke Realty	BMO Capital Markets	Upgrade
11/4/2020	Healthpeak Properties	Raymond James	Reiterated Rating
10/19/2020	Boston Properties	Evercore ISI	Downgrade
10/16/2020	Boston Properties	UBS Group	Initiated Coverage
10/16/2020	Healthpeak Properties	Mizuho	Downgrade
10/16/2020	Duke Realty	UBS Group	Initiated Coverage
9/29/2020	Duke Realty	The Goldman Sachs Group	Initiated Coverage
9/4/2020	Healthpeak Properties	Barclays	Boost Price Target
9/1/2020	Healthpeak Properties	Stifel Nicolaus	Initiated Coverage
8/21/2020	Healthpeak Properties	Morgan Stanley	Boost Price Target
8/11/2020	Duke Realty	Morgan Stanley	Boost Price Target
8/4/2020	Duke Realty	Mizuho	Boost Price Target
7/29/2020	Duke Realty	BMO Capital Markets	Reiterated Rating
7/21/2020	Duke Realty	BMO Capital Markets	Initiated Coverage

(Data available from 10/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources